Rapamycin - MyConciergeMD

Rapamycin has myriad benefits, such as treating certain cancers, cardiovascular treatments, reducing age-related diseases, etc. Although the research on its benefits is still under observation, some of the research papers document the progress.

An article by Mikhail V. Blagosklonny discusses the potential of rapamycin, an mTOR inhibitor, as an anti-aging drug. It highlights historical skepticism about anti-aging claims and emphasizes rapamycin’s proven effects on extending lifespan in various organisms [1].

Today, we will talk about Rapamycin in detail and how it can benefit patients. If you want to know more about it, talk to us at My Concierge MD.

What is Rapamycin, and what class of drugs does it belong to?

Rapamycin, also known as sirolimus and sold under the brand name Rapamune, among others, is a macrolide compound. It belongs to the class of drugs known as mTOR inhibitors.

It has immunosuppressant functions in humans and is particularly useful in preventing the rejection of kidney transplants. Additionally, rapamycin is used to coat coronary stents, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumors (PEComa).

What are the possible medical uses of Rapamycin?

  • Preventing Organ-Transplant Rejection: It acts as an immunosuppressant to prevent the body’s immune system from rejecting a transplanted organ [2].
  • Treating Certain Types of Cancer: As an antiproliferative, it helps to slow down or stop the growth of cancer cells [3].
  • Cardiovascular Treatments: Rapamycin is used as a coating for heart stents to prevent restenosis, which is the re-narrowing of arteries after they have been treated to remove blockages.

These are the main uses, but rapamycin and its analogs also have potential therapeutic benefits in antifungal, neuroprotective, neuroregenerative, and lifespan extension activities

How does Rapamycin work on a cellular level?

Rapamycin works on a cellular level by targeting and inhibiting a protein called mTOR (mechanistic target of rapamycin).

  • mTOR Pathway: mTOR is a central regulator of cell growth, proliferation, metabolism, and survival.
  • Inhibition of mTOR: When rapamycin inhibits mTOR, it disrupts the signals that tell cells to grow and divide.
  • Autophagy Stimulation: By inhibiting mTOR, rapamycin also stimulates autophagy, a process where cells clean out damaged components.
  • Immunosuppression: Rapamycin reduces the sensitivity of T cells and B cells to interleukin-2 (IL-2), which inhibits their activity and has immunosuppressant effects
Semaglutide Weight Loss Special Promotion $999
3 Month Supply of Best Compounded Semaglutdie Injection ( Ozempic, Wegovy) 
Tirzepatide Weight Loss Special Promotion $850 
1 Month Supply of Best Compounded Tirzepatide Injection ( Mounjaro, Zepbound)  
Includes
  • Virtual or In Person Office Visit with MD & Nutritionist 
  • Lab Orders To Evaluate Health & Optimize Deficiencies 
  • Continuous Support & Care! Contact Us Anytime! 
  • Medications Can Be Shipped To Your Door 
  • Lose 10-20% of Body Weight Safely 
  • 15+ Years Experience 
David

What are the potential side effects and risks associated with Rapamycin use?

Some potential side effects and risks associated with rapamycin use include:

  • Sore or Inflamed Mouth: Users may experience discomfort in the mouth area.
  • Weakened Immune System: As an immunosuppressant, it can lower the body’s ability to fight infections.
  • Anemia and Fatigue: It can cause a decrease in red blood cells, leading to tiredness.
  • Gastrointestinal Issues: Some people may experience constipation or diarrhea.
  • Elevated Cholesterol or Lipid Levels: It can affect blood lipid levels, potentially requiring management.
  • High Blood Pressure: Users might experience an increase in blood pressure.
  • Swollen Hands and Feet: Edema, or swelling, can occur.

Chronic treatment with rapamycin at immunosuppressive doses can also lead to metabolic issues like glucose intolerance, dyslipidemia, and an increased risk of developing new-onset diabetes [4].

What conditions or diseases are currently being researched for potential treatment with Rapamycin?

Rapamycin is being researched for its potential to treat and prevent a variety of conditions and diseases. Here’s a summary of the current research areas:

  • Age-Related Diseases: Studies are exploring rapamycin as a geroprotector, which could delay or prevent age-related diseases [5].
  • Cancer: There’s ongoing research into rapamycin’s ability to delay cancer, particularly lung cancer, in smokers and former smokers [6].
  • Neuroprotective/Neuroregenerative: Rapamycin has shown promise in neuroprotective and neuroregenerative activities, which could be beneficial for neurological conditions [7].
  • Lifespan Extension: Research is also looking at rapamycin for its potential to extend lifespan and reduce age-related disease [8].

Is Rapamycin approved for use in specific age groups or populations?

The FDA approved rapamycin in 1999 for use in certain populations, particularly for preventing organ rejection in transplant patients. While it has been studied for its potential anti-aging effects and other health benefits, these uses are not yet FDA-approved.

However, some sources suggest that individuals over 40 years of age who are clinically stable and in relatively good health may consider rapamycin under medical supervision.

What are some common dosages and administration methods for rapamycin?

  • Oral Solution: The liquid form is taken once daily, with or without food.
  • Tablets: These should not be crushed, chewed, or split and should be taken once daily.

The initial dose of rapamycin should be given as soon as possible after transplantation. However, the dosing may vary based on individual risk factors and other medications, such as cyclosporine.

What are some common dosages and administration methods for rapamycin

For renal transplant patients at low- to moderate-immunologic risk, a loading dose (an initial higher dose) is often given, followed by a maintenance dose (a lower dose for ongoing treatment). For example, a loading dose might be 6 mg, followed by a maintenance dose of 2 mg daily.

Cost of Rapamycin

  • Walgreens: The retail price is $489.12, but with a GoodRx coupon, it can be as low as $138.192.
  • CVS Pharmacy: Retail price is $498, but with GoodRx, it’s $110.052.
  • Walmart: The retail price is $274, but with GoodRx, it’s $81.782.
  • Harris Teeter: Retail price is $511, but with GoodRx, it’s $117.242.
  • Target (CVS): Retail price is $493, but with GoodRx, it’s $110.052.
  • Kroger Pharmacy: Retail price is $511, but with GoodRx, it’s $117.242.
  • Safeway: Retail price is $449, but with GoodRx, it’s $101.932

Rapamycin Near Me

My Concierge MD offers the best rapamycin near me in Beverly Hills but can also come to your home or office throughout the Los Angeles area. We serve patients near Beverly Hills, Bel Air, West Hollywood, Santa Monica, West Los Angeles, Culver City, Hollywood, Venice, Marina del Rey, Malibu, Manhattan Beach, Redondo Beach, Downtown Los Angeles, Encino, Woodland Hills, Sherman Oaks, Calabasas, Burbank, Glendale, Hidden Hills, Agoura Hills, Northridge, North Hollywood, Topanga, Canoga Park, Reseda, Valley Glen, Chatsworth, West Hills, Winnetka, Universal City, Silverlake, Echo Park, and many more.

References:

  1. Blagosklonny MV. Rapamycin for longevity: opinion article. Aging (Albany NY). 2019;11(19):8048-8067. doi:10.18632/aging.102355
  2. Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol. 1977 Feb;55(1):48-51. doi: 10.1139/y77-007. PMID: 843990.
  3. Young Ji Yoo, Hanseong Kim, Sung Ryeol Park, Yeo Joon Yoon, An overview of rapamycin: from discovery to future perspectives, Journal of Industrial Microbiology and Biotechnology, Volume 44, Issue 4-5, 1 May 2017, Pages 537–553, https://doi.org/10.1007/s10295-016-1834-7
  4. Konopka, A.R., Lamming, D.W., RAP PAC Investigators. et al. Blazing a trail for the clinical use of rapamycin as a geroprotecTOR. GeroScience 45, 2769–2783 (2023). https://doi.org/10.1007/s11357-023-00935-x
  5. Konopka, A.R., Lamming, D.W., RAP PAC Investigators. et al. Blazing a trail for the clinical use of rapamycin as a geroprotecTOR. GeroScience 45, 2769–2783 (2023). https://doi.org/10.1007/s11357-023-00935-x
  6. Blagosklonny M. V. Cancer prevention with rapamycin. Oncotarget. 2023; 14: 342-350. Retrieved from https://www.oncotarget.com/article/28410/text/
  7. Young Ji Yoo, Hanseong Kim, Sung Ryeol Park, Yeo Joon Yoon, An overview of rapamycin: from discovery to future perspectives, Journal of Industrial Microbiology and Biotechnology, Volume 44, Issue 4-5, 1 May 2017, Pages 537–553, https://doi.org/10.1007/s10295-016-1834-7
  8. Selvarani, R., Mohammed, S. & Richardson, A. Effect of rapamycin on aging and age-related diseases—past and future. GeroScience 43, 1135–1158 (2021). https://doi.org/10.1007/s11357-020-00274-1

As Seen On

Your-Concierge-MD-Clients

extra-logo
As Featured on Extra TV